UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________

 

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________to_________

 

Commission File Number

000-19932

RELIV’ INTERNATIONAL, INC.

(Exact name of Registrant as specified in its charter)

Delaware 371172197
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)
   
136 Chesterfield Industrial Boulevard,     Chesterfield, Missouri 63005
(Address of principal executive offices) (Zip Code)

                                                  

(636) 537-9715

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☑     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ☑     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐  Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes ☐     No ☑

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001

RELV

NASDAQ Capital Market

 

The number of shares outstanding of the Registrant’s common stock as of August 5, 2019 was 1,746,449 (excluding treasury shares).

 

 

 
 

 

INDEX   

 

 

Part I – Financial Information       
     
Item No. 1 Financial Statements (Unaudited) 1
Item No. 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
Item No. 4 Controls and Procedures 25
     
Part II – Other Information  
     
Item No. 6 Exhibits 26

 

 

 
 

 

PART I -- FINANCIAL INFORMATION

 

Item No. 1 - Financial Statements

 

Reliv International, Inc. and Subsidiaries

 

Condensed Consolidated Balance Sheets

   

June 30

   

December 31

 
   

2019

   

2018

 
   

(unaudited)

         

Assets

               
                 

Current assets:

               

Cash and cash equivalents

  $ 1,918,721     $ 1,989,974  

Accounts receivable, less allowances of $5,000 in 2019 and 2018

    235,030       400,759  

Notes & accounts receivables and deposits - related parties

    1,027,126       151,222  

Inventories

               

Finished goods

    2,262,547       2,460,563  

Raw materials

    325,513       372,865  

Sales aids and promotional materials

    121,095       121,519  

Total inventories

    2,709,155       2,954,947  
                 

Refundable income taxes

    26,007       22,712  

Assets held for sale

    -       2,124,939  

Prepaid expenses and other current assets

    740,027       441,453  

Total current assets

    6,656,066       8,086,006  
                 

Other assets

    407,781       338,974  

Notes and accounts receivables - related parties

    2,490,528       1,282,072  

Operating lease right-to-use assets

    337,858       -  

Intangible assets, net

    1,835,269       1,948,263  

Equity investment

    505,000       -  
                 

Property, plant and equipment:

               

Land and land improvements

    905,190       905,190  

Building

    10,113,184       9,964,523  

Office & other equipment

    1,226,930       1,337,911  

Computer equipment & software

    2,227,896       2,212,935  
      14,473,200       14,420,559  

Less: Accumulated depreciation

    9,903,963       9,722,009  

Net property, plant and equipment

    4,569,237       4,698,550  
                 

Total assets

  $ 16,801,739     $ 16,353,865  

 

See notes to financial statements.

 

1

 

 

Reliv International, Inc. and Subsidiaries

 

Condensed Consolidated Balance Sheets

   

June 30

   

December 31

 
   

2019

   

2018

 
   

(unaudited)

         

Liabilities and stockholders' equity

               
                 

Current liabilities:

               

Accounts payable and accrued expenses:

               

Trade accounts payable and other accrued expenses

  $ 1,918,264     $ 2,105,814  

Distributors' commissions payable

    886,452       1,030,948  

Sales taxes payable

    147,444       195,802  

Payroll and payroll taxes payable

    239,222       210,288  

Total accounts payable and accrued expenses

    3,191,382       3,542,852  
                 

Income taxes payable

    52,618       35,304  

Deferred revenue

    356,855       337,234  

Operating lease liabilities

    211,278       -  

Deferred rent liability

    125,000       -  

Revolving line of credit

    500,000       -  

Total current liabilities

    4,437,133       3,915,390  
                 

Noncurrent liabilities:

               

Operating lease liabilities

    119,106       -  

Other noncurrent liabilities

    507,595       445,611  

Total noncurrent liabilities

    626,701       445,611  
                 

Stockholders' equity:

               

Preferred stock, par value $.001 per share; 500,000 shares authorized; -0- shares issued and outstanding in 2019 and 2018

    -       -  

Common stock, par value $.001 per share; 5,000,000 authorized; 2,110,013 shares issued and 1,746,449 shares outstanding as of 6/30/2019; 2,110,013 shares issued and 1,845,160 shares outstanding as of 12/31/2018

    2,110       2,110  

Additional paid-in capital

    30,633,159       30,622,547  

Accumulated deficit

    (12,075,599 )     (12,311,138 )

Accumulated other comprehensive loss:

               

Foreign currency translation adjustment

    (970,342 )     (982,095 )

Treasury stock

    (5,851,423 )     (5,338,560 )
                 

Total stockholders' equity

    11,737,905       11,992,864  
                 

Total liabilities and stockholders' equity

  $ 16,801,739     $ 16,353,865  

 

See notes to financial statements.

 

2

 
 

 

Reliv International, Inc. and Subsidiaries

 

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)

 

(unaudited)

 

Three months ended June 30

   

Six months ended June 30

 
   

2019

   

2018

   

2019

   

2018

 
                                 
                                 
                                 

Product sales

  $ 7,603,041     $ 7,920,596     $ 16,414,038     $ 17,311,977  

Freight income

    479,881       539,145       999,822       1,151,003  

Other revenue

    174,091       -       332,657       -  
                                 

Net sales

    8,257,013       8,459,741       17,746,517       18,462,980  
                                 

Costs and expenses:

                               

Cost of goods sold

    2,268,992       2,356,274       4,702,723       4,706,016  

Distributor royalties and commissions

    2,665,093       2,827,357       5,782,665       6,219,102  

Selling, general and administrative

    3,688,944       4,215,641       7,428,472       8,701,536  
                                 

Total costs and expenses

    8,623,029       9,399,272       17,913,860       19,626,654  
                                 

Loss from operations

    (366,016 )     (939,531 )     (167,343 )     (1,163,674 )
                                 

Other income (expense):

                               

Interest income

    46,218       23,547       95,480       47,499  

Interest expense

    (10,075 )     (45,222 )     (15,487 )     (76,787 )

Other income (expense)

    4,768       7,214       (660 )     13,865  

Gain (loss) on sale of fixed assets

    -       (962 )     434,549       2,838  
                                 

Income (loss) before income taxes

    (325,105 )     (954,954 )     346,539       (1,176,259 )

Provision for income taxes

    63,000       23,000       111,000       40,000  
                                 

Net income (loss)

  $ (388,105 )   $ (977,954 )   $ 235,539     $ (1,216,259 )
                                 

Other comprehensive income (loss):

                               

Foreign currency translation adjustment

    (10,458 )     (78,591 )     11,753       (53,363 )
                                 

Comprehensive income (loss)

  $ (398,563 )   $ (1,056,545 )   $ 247,292     $ (1,269,622 )
                                 
                                 

Earnings (loss) per common share - Basic

  $ (0.22 )   $ (0.53 )   $ 0.13     $ (0.66 )

Weighted average shares

    1,746,000       1,845,000       1,746,000       1,845,000  
                                 

Earnings (loss) per common share - Diluted

  $ (0.22 )   $ (0.53 )   $ 0.13     $ (0.66 )

Weighted average shares

    1,746,000       1,845,000       1,746,000       1,845,000  

 

See notes to financial statements.

 

3

 
 

 

Reliv International, Inc. and Subsidiaries

 

Condensed Consolidated Statements of Cash Flows

(unaudited)

   

Six months ended June 30

 
   

2019

   

2018

 
                 

Operating activities:

               

Net income (loss)

  $ 235,539     $ (1,216,259 )

Adjustments to reconcile net income (loss) to net cash used in operating activities:

               

Depreciation and amortization

    292,842       403,430  

Stock-based compensation

    10,612       15,069  

Non-cash life insurance policy reduction / (accretion)

    -       19,162  

Non-cash other revenue

    (172,866 )     -  

Non-cash miscellaneous loss

    24,618       -  

(Gain) loss on sale of property, plant and equipment

    (434,549 )     (2,838 )

Foreign currency transaction (gain) loss

    1,149       (194 )

(Increase) decrease in trade, accounts & notes receivable, and deposits from related parties

    (715,018 )     (180,145 )

(Increase) decrease in inventories

    758,798       415,760  

(Increase) decrease in refundable income taxes

    (3,295 )     3,616  

(Increase) decrease in prepaid expenses and other current assets

    (295,925 )     (274,252 )

(Increase) decrease in other assets

    (68,807 )     (948 )

Increase (decrease) in income taxes payable

    16,148       (6,930 )

Increase (decrease) in accounts payable & accrued expenses, deferred revenue, and other noncurrent liabilities

    (293,111 )     568,291  
                 

Net cash used in operating activities

    (643,865 )     (256,238 )
                 

Investing activities:

               

Purchase of property, plant and equipment

    (50,180 )     (56,968 )

Proceeds from the sale of property, plant and equipment

    -       3,888  

Payments received on notes receivables - related parties

    109,984       57,079  
                 

Net cash provided by investing activities

    59,804       3,999  
                 

Financing activities:

               

Proceeds from line of credit borrowings

    500,000       -  

Principal payments on long-term borrowings

    -       (189,560 )
                 

Net cash provided by (used in) financing activities

    500,000       (189,560 )
                 

Effect of exchange rate changes on cash and cash equivalents

    12,808       (66,901 )
                 

Increase (decrease) in cash and cash equivalents

    (71,253 )     (508,700 )
                 

Cash and cash equivalents at beginning of period

    1,989,974       3,272,788  
                 

Cash and cash equivalents at end of period

  $ 1,918,721     $ 2,764,088  
                 
Supplementary disclosure of cash flow information:                
Noncash investing & financing transactions (Note 3):                

 

See notes to financial statements.

 

4

 
 

 

Reliv International, Inc. and Subsidiaries

 

Condensed Consolidated Statements of Stockholders' Equity

 

(unaudited)

                                   

Accumulated

                         
                   

Additional

           

Other

                         
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Treasury Stock

         
   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Shares

   

Amount

   

Total

 

Balance at December 31, 2018

    2,110,013     $ 2,110     $ 30,622,547     $ (12,311,138 )   $ (982,095 )     264,853     $ (5,338,560 )   $ 11,992,864  

Net income

    -       -       -       623,644       -       -       -       623,644  

Other comprehensive income (loss):

                                                               

Foreign currency translation adjustment

    -       -       -       -       22,211       -       -       22,211  

Total comprehensive income

                                                            645,855  

Treasury stock acquired (Note 2)

    -       -       -       -       -       99,200       (540,144 )     (540,144 )

Other

    -       -       -       -       -       (489 )     27,281       27,281  

Stock-based compensation

    -       -       5,306       -       -       -       -       5,306  

Balance at March 31, 2019

    2,110,013       2,110       30,627,853       (11,687,494 )     (959,884 )     363,564       (5,851,423 )     12,131,162  

Net loss

    -       -       -       (388,105 )     -       -       -       (388,105 )

Other comprehensive income (loss):

                                                               

Foreign currency translation adjustment

    -       -       -       -       (10,458 )     -       -       (10,458 )

Total comprehensive loss

                                                            (398,563 )

Stock-based compensation

    -       -       5,306       -       -       -       -       5,306  

Balance at June 30, 2019

    2,110,013     $ 2,110     $ 30,633,159     $ (12,075,599 )   $ (970,342 )     363,564     $ (5,851,423 )   $ 11,737,905  

 

 

                                   

Accumulated

                         
                   

Additional

           

Other

                         
   

Common Stock

   

Paid-In

   

Accumulated

   

Comprehensive

   

Treasury Stock

         
   

Shares

   

Amount

   

Capital

   

Deficit

   

Loss

   

Shares

   

Amount

   

Total

 

Balance at December 31, 2017

    2,110,013     $ 2,110     $ 30,598,920     $ (10,040,229 )   $ (857,654 )     264,853     $ (5,338,560 )   $ 14,364,587  

Net loss

    -       -       -       (238,305 )     -       -       -       (238,305 )

Other comprehensive income (loss):

                                                               

Foreign currency translation adjustment

    -       -       -       -       25,228       -       -       25,228  

Total comprehensive loss

                                                            (213,077 )

Adoption of Accounting Standards Update 2014-09

    -       -       -       (367,568 )     -       -       -       (367,568 )

Stock-based compensation

    -       -       7,534       -       -       -       -       7,534  

Balance at March 31, 2018

    2,110,013       2,110       30,606,454       (10,646,102 )     (832,426 )     264,853       (5,338,560 )     13,791,476  

Net loss

    -       -       -       (977,954 )     -       -       -       (977,954 )

Other comprehensive income (loss):

                                                               

Foreign currency translation adjustment

    -       -       -       -       (78,591 )     -       -       (78,591 )

Total comprehensive loss

                                                            (1,056,545 )

Stock-based compensation

    -       -       7,535       -       -       -       -       7,535  

Balance at June 30, 2018

    2,110,013     $ 2,110     $ 30,613,989     $ (11,624,056 )   $ (911,017 )     264,853     $ (5,338,560 )   $ 12,742,466  

 

See notes to financial statements.

 

5

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

June 30, 2019

 

 

1. Accounting Polic ies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which we believe are necessary to present fairly the financial position, results of operations and cash flows. All significant intercompany accounts and transactions have been eliminated. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2018, filed March 29, 2019 with the Securities and Exchange Commission.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

Reclassifications

 

To conform to the current year presentation, certain previously reported 2018 amounts have been reclassified. 

 

Inventories

 

Inventories are valued at the lower of cost or market and are accounted for on a first-in, first-out basis. Effective January 1, 2019, finished goods inventories primarily consist of purchased products held for resale. Prior to 2019, finished goods inventories were primarily comprised of internally manufactured products consisting of the costs associated with raw materials, labor, and overhead. On a periodic basis we review our inventory levels, as compared to future demand requirements and the shelf life of the various products. Based on this review, we record inventory write-downs when necessary.

 

Sales aids and promotional materials inventories represent distributor kits, product brochures, and other sales and business development materials which are held for sale to distributors. Cost of the sales aids and promotional materials held for sale are capitalized as inventories and subsequently recorded to costs of goods sold upon recognition of revenue when sold to distributors. All other advertising and promotional costs are expensed when incurred.

 

6

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

1. Accounting Policies (continued)

 

Variable Interest Entities (VIE) - Unconsolidated

 

Effective January 1, 2019, we have a financial interest in Nutracom LLC (Nutracom). If we are the primary beneficiary of a VIE, we are required to consolidate the VIE in our consolidated financial statements. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our VIE evaluation requires significant assumptions and judgments.

 

We do not have the power to direct the significant activities of Nutracom, primarily because we do not have governance rights. We also do not participate in the annual profits or losses of Nutracom. Therefore, we do not consolidate the financial results of Nutracom in our consolidated financial statements. We account for our financial interest in Nutracom as an equity investment measured at cost minus impairment, if any. A cost method equity investment is subject to periodic impairment review using the other-than-temporary impairment model, which considers the severity and duration of a decline in fair value below cost and our ability and intent to hold the investment for a sufficient period of time to allow for recovery.

 

See Note 2 and Note 3 for further information on our financial relationship with Nutracom.

 

Concentrations of Risk

 

Effective January 1, 2019, we have entered into outsourcing agreements with Nutracom to manufacture our nutritional and dietary supplements and for warehousing and fulfillment services for the U.S. distribution of our products. Nutracom has also issued promissory notes to us for the acquisition of our manufacturing and fulfillment operations. Any inability of Nutracom to deliver these contracted services or to repay the promissory notes could adversely impact our future operating results. See Note 2 and Note 3 for further discussion of our relationship with Nutracom.

 

New Accounting Pronouncements – Not Yet Adopted

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updated (“ASU”) No. 2016-13, Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments which requires entities to use a current lifetime expected credit loss methodology to measure impairments of certain financial assets. Using this methodology may result in earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of having been incurred. There are other provisions within the standard that affect how impairments of other financial assets may be recorded and presented, and that expand disclosures. This standard will be effective for our interim and annual financial periods beginning January 1, 2020, with early adoption permitted. Adoption of this standard must be applied on a modified retrospective basis. We are evaluating the potential impact of this standard on our consolidated financial statements and related disclosures.

 

7

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

1. Accounting Policies (continued)

 

New Accounting Pronouncements – Adopted January 1, 2019

 

Lessee Accounting

On January 1, 2019, we adopted ASU No. 2016-02, Leases (Topic 842) (including subsequent issued lease-related ASU’s), and applied the new lease accounting standard to all lessee operating leases using the prospective transition method. Under this method, prior financial reporting periods are not restated. The adoption of the new lease accounting standard resulted in the recording of assets and obligations of our operating leases of approximately $451,000 and $457,000, respectively, on our consolidated balance sheets. Certain amounts previously recorded for prepaid and accrued rent associated with historical operating leases were reclassified to the newly captioned Operating lease right-to-use assets.

 

At adoption, we used the new lease accounting standard’s package of practical expedients permitted under the transition guidance that allowed us to not reassess: (a) whether any expired or existing contracts are or contain leases, (b) lease classification for any expired or existing leases, and (c) initial direct costs for any expired or existing leases. We also used the lease standard’s practical expedient that allows lessees to treat the lease and implicit non-lease components of our leases as a single lease component and we do not record on the balance sheet leases with an initial term of twelve months or less. Fixed lease expense on all of our operating leases is recognized on a straight-line basis over the contractual lease term, including our estimate of any renewal or early termination lease terms. Operating lease expense is presented within Selling, General and Administrative expense in our operating results.

 

Operating lease liabilities and related operating lease right-to-use assets are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When leases do not provide an implicit discount rate, we use a country specific incremental borrowing rate based upon the lease term.

 

See Note 7 for additional lease disclosures.

 

Less or Accounting – Other Revenue

 

Other revenue consists of revenue derived from our leasing a portion of our headquarters building to Nutracom, LLC (Nutracom). We recognize lessor rent revenue on a straight-line basis over the term of the lease. As part of this straight-line methodology, the cumulative rental billings may be greater or less than the financial period’s recognized revenue; such timing differences are recognized on the balance sheet as an accrued other liability or an unbilled rent revenue receivable.

 

Also included in other revenue are billings to the tenant for its share of the facility’s common area costs such as real estate taxes, maintenance, and utilities. These same common area costs plus the tenant’s share of the facilities’ depreciation are recorded as cost of goods sold.

 

See Note 2 and Note 3 for further information on our financial relationship with Nutracom. See Note 7 for further information on our leases.

 

8

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

1. Accounting Policies (continued)

 

Going Concern

 

We have incurred operating losses, declining net sales, and negative net cash flows over our most recent five years. Our management estimates that these unfavorable trends are more likely than not to continue for the foreseeable future, and as a result, we will require additional financial support to fund our operations and execute our business plan. As of June 30, 2019, we had $1,918,721 in cash and cash equivalents which may not be sufficient to fund our planned operations through one year subsequent to the date of the issuance of these condensed financial statements, and accordingly, there is substantial doubt about our ability to continue as a going concern. The analysis used to determine our ability to continue as a going concern does not include cash sources outside of our direct control that our management expects to be available within the next twelve months.

 

We may not be able to obtain sufficient additional funding through monetizing certain of our existing assets, sourcing additional borrowings, and issuing additional equity, or any other means, and if we are able to do so, these available sources of funds may not be on satisfactory terms. Our ability to raise additional capital in the equity markets, should we choose to do so, is dependent on a number of factors, including, but not limited to, the market demand for our common stock, which itself is subject to a number of business risks and uncertainties, as well as the uncertainty that we would be able to raise such additional capital at a price or on terms that we believe are favorable.

 

We have taken several steps in 2019 which we believe will result in improvement to our financial position, operating results, and cash flows. We have borrowed $500,000 of our available $750,000 revolving line of credit balance. In addition, our lender has agreed to extend the available $750,000 revolving line of credit agreement to April 28, 2020.

 

As detailed in Note 2 of these condensed consolidated financial statements, on January 1, 2019, we sold the assets previously used by us in our manufacturing operations to Nutracom LLC (Nutracom). We financed the assets purchased by Nutracom from us under payment terms scheduled to provide incoming funds to us of $100,000 or more per year. We have also entered into an agreement for Nutracom to lease a significant portion of our headquarters building. Our management believes that these transactions with Nutracom will be favorable to our financial position, operating results, and cash flows; however, there are risks and uncertainties which arise from these Nutracom transactions and their impact to our operations.

 

Should the aforementioned changes to our operations not provide sufficient cash flow improvement or should we be unable to obtain sufficient additional capital or borrowings, we may have to engage in any or all of the following activities: (i) seek to monetize our headquarters building via traditional bank lending or a sale and leaseback-type transaction; (ii) monetizing the note receivable from a distributor; (iii) modify our distributor promotions, incentives, and other activities; (iv) cease operations in certain geographic regions, and (v) reduce employee compensation and benefits.

 

These actions may have a material adverse impact on our ability to achieve certain of our planned objectives. Even if we are able to source additional funding, we may be forced to significantly reduce our operations or shut down our operations if our business operating performance does not improve. These condensed consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary in the event we can no longer continue as a going concern.

 

9

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

2. Sale of Manufacturing Operations’ Assets

 

On January 1, 2019, we entered into a Purchase Agreement with Nutracom, LLC (Nutracom) pursuant to which Nutracom purchased the following assets previously used by us in our manufacturing operations:

 

 

Inventories (sold at cost of $1.56 million) and,

 

Machinery and other equipment with a net book value of $565,000 (sold for $1 million; gain on disposal of approximately $435,000).

 

Nutracom was formed by our manufacturing operations management which included former officers of the Company. Employees of our manufacturing operations were offered employment by Nutracom.

 

Prior to its approval of the transaction, our Board of Directors formed a special committee consisting of the Board’s independent directors to review the transaction. To assist in its review, the special committee engaged a qualified third-party expert to render a fairness opinion on the transaction.

 

Concurrently with the execution of the Purchase Agreement, we entered into several agreements with Nutracom including a product supply agreement for a term of seven years, a fulfillment agreement, and a facility lease agreement whereby Nutracom will lease manufacturing, warehouse, and certain office space of our headquarters building from us for a term of seven years, with a Nutracom option for an additional five-year term. Annual lease amounts range from $193,000 to $410,000 over the seven-year term.

 

Nutracom provided the following consideration to us for the manufacturing operations and related identified assets and agreements:

 

 

$1 million secured promissory note, seven year term, fixed interest rate of 5.5%, principal and interest payable monthly. (See June 1, 2019 note modification within this Note 2).

 

$764,344 unsecured promissory note, seven year term, fixed interest rate of 7.0%, interest only payable for the first two years with monthly payment of principal and interest thereafter under a ten-year amortization schedule. The face value of the unsecured note includes the first year’s rent due under the facility lease agreement.

 

Nutracom management transferred to us its ownership of 99,200 shares of our common stock valued at $540,144.

 

Nutracom issued to us a non-voting Class B 15% equity membership interest in Nutracom, LLC. The Class B interest does not share in any profits or losses from operations of Nutracom. As defined within the Nutracom Operating Agreement, upon any merger, consolidation, disposition, or liquidation of Nutracom, the Class B equity membership interest converts to a Class A equity membership interest.

 

Commencing January 1, 2020, our Class B interest will be entitled to receive a percentage, (ranging from 1.0% to 1.25%) of Nutracom’s annual revenues (excluding Nutracom’s revenues from sales to us).

 

Our non-voting Class B 15% equity membership interest in Nutracom was valued by the aforementioned third-party expert at $505,000. As our non-voting membership interest does not participate in the management of Nutracom, nor do we share in any Nutracom operating profits or losses, we are accounting for our Nutracom equity investment under the cost method.

 

At December 31, 2018, we presented inventories and machinery and other equipment sold to Nutracom as a current asset under the caption of “Assets held for sale” in the accompanying condensed consolidated balance sheets. We have accounted for the Nutracom aforementioned transactions in our first quarter 2019 financial results.

 

Promissory Note Modification – June 1, 2019

 

On June 1, 2019, we entered into an Agreement with Nutracom to modify the Secured Promissory Note originally issued to us by Nutracom on January 1, 2019, as follows:

 

 

Effective June 1, 2019, the outstanding balance of the Secured Promissory Note was reduced by $500,000 to $460,583 with a corresponding reduction of $500,000 to our outstanding vendor obligation due Nutracom under our ongoing product supply agreement.

 

The $460,583 remaining Secured Promissory Note was exchanged with Nutracom for a newly issued June 1, 2019 Nutracom unsecured promissory note for the same amount under the following terms: fixed interest rate of 6.0% with interest only payable monthly through December 2020. Beginning January 1, 2021, principal and interest of $8,904 will be payable monthly for 60 months.

 

10

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

3. Related Parties

 

The following summarizes our related party activities with Nutracom and a significant distributor of the Company.

 

   

June 30

   

December 31

 

Assets and liabilities - related parties

 

2019

   

2018

 
                 

Notes & accounts receivables and deposits - current

               

Deposits with Nutracom for inventory

  $ 827,356     $ -  

Notes receivable - distributor

    126,778       123,040  

Other miscellaneous receivables

    72,992       28,182  
    $ 1,027,126     $ 151,222  
                 
                 

Notes & accounts receivables - non-current

               

Notes receivable - distributor

  $ 1,217,735     $ 1,282,072  

Notes receivable - Nutracom unsecured DTD 1/1/2019

    764,344       -  

Notes receivable - Nutracom unsecured DTD 6/1/2019

    460,583       -  

Unbilled receivables: Straight line rent revenue greater than rental billings

    47,866       -  
    $ 2,490,528     $ 1,282,072  
                 
                 

Equity investment in Nutracom

  $ 505,000       -  
                 

Liability captions with Nutracom balances included therein

               

Trade accounts payable and other accrued expenses

  $ 62,849       -  

Deferred rent liability

    125,000       -  

 

The following table presents scheduled principal payments to be received on the distributor and Nutracom promissory notes receivable:

 

Remainder of 2019

  $ 62,441  

2020

    130,629  

2021

    274,844  

2022

    292,377  

2023

    311,033  

Thereafter

    1,498,116  
    $ 2,569,440  

 

11

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

3. Related Parties (continued)

 

   

Six months ended June 30

 

Revenue and expense - related parties

 

2019

   

2018

 
                 

Other revenue

  $ 332,657     $ -  
                 

Selling, general and administrative expense:

               

Fullfillment & professional fees

    305,910       -  
                 

Interest income on promissory notes

    92,668       44,778  

Gain on sale of fixed assets

    434,549       -  
                 

Finished goods inventory purchased from Nutracom

  $ 2,763,000       -  

 

At June 30, 2019, we had $1.4 million in commitments (net of deposits) to purchase finished goods inventory from Nutracom.

 

S upplementary Disclosure of Cash Flows Information :

 

We incurred the following noncash investing and financing transactions on January 1, 2019 and June 1, 2019 relating to our transactions with Nutracom:

 

   

2019

 
         

January 1, 2019

       

Sale of fixed assets

  $ 1,000,000  

Sale of inventories

    1,559,488  

First year building rental received in advance

    250,000  

Acquire company common stock for treasury

    540,144  

Acquire equity investment in Nutracom

    505,000  

Secured promissory note received

    1,000,000  

Unsecured promissory note received

    764,344  
         

June 1, 2019

       

Secured promissory note receivable balance decreased; applied as reduction to outstanding trade accounts payable

    500,000  

Unsecured promissory note received in exchange for remaining secured promissory note balance and other considerations

    460,583  

 

12

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

4. Basic and Diluted Earnings (Loss) per Share

 

Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock.

 

The following table sets forth the computation of basic and diluted earnings (loss) per share:

 

   

Three months ended

   

Six months ended

 
   

June 30

   

June 30

 
   

2019

   

2018

   

2019

   

2018

 

Numerator:

                               

Net income (loss)

  $ (388,105 )   $ (977,954 )   $ 235,539     $ (1,216,259 )

Denominator:

                               

Denominator for basic earnings (loss) per share – weighted average shares

    1,746,000       1,845,000       1,746,000       1,845,000  

Dilutive effect of employee stock options and other warrants

    -       -       -       -  

Denominator for diluted earnings (loss) per share – adjusted weighted average shares

    1,746,000       1,845,000       1,746,000       1,845,000  
                                 

Basic earnings (loss) per share

  $ (0.22 )   $ (0.53 )   $ 0.13     $ (0.66 )

Diluted earnings (loss) per share

  $ (0.22 )   $ (0.53 )   $ 0.13     $ (0.66 )

 

Options and warrants to purchase 85,203 shares of common stock for the three months and six months ended June 30, 2019, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable. Options and warrants to purchase 120,242 shares of common stock for the three months and six months ended June 30, 2018, respectively, were not included in the denominator for diluted earnings (loss) per share because their effect would be antidilutive or because the shares were deemed contingently issuable.

 

13

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

5 . Fair Value of Financial Instruments

 

Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels:

 

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active.

 

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

 

The carrying amount and fair value of financial instruments were approximately as follows:

 

   

Carrying

   

Fair

                         

Description

 

Amount

   

Value

   

Level 1

   

Level 2

   

Level 3

 
                                         

June 30, 2019

                                       

Revolving line of credit

  $ 500,000     $ 500,000       -     $ 500,000       -  

Note receivable - distributor

    1,344,513       1,474,000       -       1,474,000       -  

Notes receivable - Nutracom

    1,224,927       1,224,927       -       1,224,927       -  

Marketable securities

    408,000       408,000     $ 408,000       -       -  
                                         

December 31, 2018

                                       

Note receivable - distributor

  $ 1,405,112     $ 1,529,000       -     $ 1,529,000       -  

Marketable securities

    339,000       339,000     $ 339,000       -       -  

 

Revolving line of credit : The fair value of our revolver loan approximates carrying value as this loan was amended within the past year and has a variable market-based interest rate that resets every thirty days.

 

Note receivable - distributor : The note receivable - distributor is a variable rate residential mortgage-based financial instrument. An average of published interest rate quotes for a fifteen-year residential jumbo mortgage, a comparable financial instrument, was used to estimate fair value of this note receivable under a discounted cash flow model.

 

Note s receivable - Nutracom : The fair value of the notes receivable – Nutracom balance approximates carrying value as these notes were received at fair value within the current fiscal year.

 

Marketable securities : The assets (trading securities) of our Supplemental Executive Retirement Plan are recorded at fair value on a recurring basis, and are presented within Other Assets in the consolidated balance sheets.

 

The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of the respective balances.

 

14

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

6 . Debt

 

On September 30, 2015, we entered into a series of lending agreements with our primary lender which included agreements for a term loan and a revolving credit facility. The term loan was repaid in 2018 and the revolver has been periodically amended and extended.

 

Effective with a September 11, 2018 amendment, the revolving line of credit’s maximum borrowing amount was $750,000. The revolver’s maturity date was April 29, 2019 and the revolver’s interest rate was based on the 30-day LIBOR plus 2.25%. As of December 31, 2018, there were no outstanding borrowings on the revolving line of credit. In January 2019, the Company borrowed $500,000 under its revolving line of credit.

 

Effective with a March 25, 2019 amendment, the revolving line of credit’s maturity date was extended to April 28, 2020 and the interest rate was revised to the 30-day LIBOR plus 3.00%. As amended, the revolver’s maximum borrowing amount remains $750,000. At June 30, 2019, outstanding borrowings under the revolving line of credit were $500,000 at an interest rate of 5.48%.

 

Borrowings under the lending agreement continue to be secured by all of our tangible and intangible assets and by a mortgage on the real estate of our headquarters facility. At June 30, 2019, the Company was in compliance with its loan covenant requirements.

 

 

7. Leases

 

Less ee

 

The Company leases certain office facilities, storage, and equipment. These leases have varying terms, are generally one to five years in length, and certain real estate leases have options to extend or early terminate. Several of our operating leases are subject to annual changes in the Consumer Price or similar indexes (CPI). The changes to the lease payment due to CPI changes are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.

 

The following table represents the maturity of our operating lease liabilities as of June 30, 2019:

 

Remainder of 2019

  $ 118,728  

2020

    185,980  

2021

    19,588  

2022

    14,781  

2023

    5,557  

Thereafter

    -  

Total operating lease payments

    344,634  

Less: imputed interest

    (14,250 )

Total operating lease liabilities

  $ 330,384  

 

Operating lease expense:

 

Three months ended

   

Six months ended

 
   

June 30, 2019

   

June 30, 2019

 

Fixed

  $ 60,269     $ 124,972  

Variable

    4,023       9,472  

Short-term

    5,265       15,036  

Total

  $ 69,557     $ 149,480  

 

As of June 30, 2019, our operating leases have a weighted-average remaining lease term of 1.8 years and a weighted-average discount rate of 5.2%. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $134,600 for the six months ended June 30, 2019.

 

Less or – Other Revenue

 

Other revenue consists of revenue derived from our leasing a portion of our headquarters building to Nutracom, LLC (Nutracom) effective January 1, 2019. The leased space, encompassing manufacturing, warehouse, and certain office space, is for a term of seven years, with a tenant option for an additional five-year term. Annual lease amounts range from $193,000 to $410,000 over the seven-year term.

 

We recognize lessor rent revenue on a straight-line basis over the term of the lease. As part of this straight-line methodology, the cumulative rental billings may be greater or less than the financial period’s recognized revenue; such timing differences are recognized on the balance sheet as an accrued other liability or an unbilled rent revenue receivable.

 

Also included in other revenue are billings to the tenant for its share of the facility’s common area costs such as real estate taxes, maintenance, and utilities. These same common area costs plus the tenant’s share of the facilities’ depreciation are recorded as cost of goods sold.

 

15

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

7. Leases (continued)

 

Less or – Other Revenue (continued)

 

The following table details lessor’s estimated remaining straight-line rent revenue over the seven-year lease term as compared with fixed rent amounts under the lease agreement.

 

   

Estimated

         
   

Straight-line

   

Lease Agreement

 
   

Rent Revenue

   

Fixed Rent

 
                 

Remainder of 2019

  $ 172,866     $ 125,000  

2020

    345,732       192,900  

2021

    345,732       385,800  

2022

    345,732       385,800  

2023

    345,732       385,800  

Thereafter

    691,465       819,825  

Total

  $ 2,247,259     $ 2,295,125  

 

 

 

8 . Income Taxes

 

During the fiscal years of 2016 through 2018, we determined that it was more likely than not that U.S. federal and various state net operating losses generated in those years will not be realized based on projections of future U.S. taxable income, estimated reversals of existing taxable timing differences, and other considerations.

 

In prior years, we recorded a valuation allowance on all of our domestic and foreign deferred tax assets. The effective income tax rate was 32.0% and (3.4)% for the year to date periods ended June 30, 2019 and 2018, respectively. The income tax provision amounts primarily represent estimated income taxes for one of the Company’s foreign subsidiaries and certain U.S. states.

 

One of our foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 plus interest at 20% per annum) in value-added tax (VAT) and withholding tax for the years 2004 through 2006. In consultation with our legal counsel, we believe that there are strong legal grounds that we should not be liable to pay the majority of the alleged tax deficiencies. In 2011, we made good faith deposits of approximately $173,000 to the local tax authority under the tax agency’s administrative judicial resolution process.

 

As of December 31, 2018, our estimated reserve (net of deposits) for this matter was approximately $172,500 and remains unchanged in 2019. In May 2018, we received a formal notice of denial of one of our appeals under the tax agency’s administrative judicial resolution process; however, we continue to pursue other available legal processes as we continue to maintain our position that we are not liable for the majority of the alleged tax deficiencies.

 

16

 

 

Reliv’ International, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

(Unaudited)

 

 

9 . Revenue Recognition

 

We recognize revenue from product sales under a five step process with our independent distributors (including customers) when there is a legally enforceable contract, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. Product sales revenue (principally nutritional and dietary supplements) and commission expenses are recorded when control is transferred to the independent distributors, which occurs at the time of shipment. Generally, net sales reflect product sales less the distributor discount of 20 percent to 40 percent of the suggested retail price. We present distributor royalty and commission expense as an operating expense, rather than a reduction to net sales, as these payments are not made to the purchasing distributor. At point of sale, we receive payment by credit card, personal check, or guaranteed funds for contracts from independent distributors and make related commission payments in the following month.

 

We recognize the performance obligation for membership fees-type revenue over the membership term of generally twelve months. We receive payment for membership fees revenue at the beginning of the membership term and recognize membership fees revenue on a straight-line basis in correlation with the completion of our performance obligation under the membership term. Our remaining unearned membership fees obligation is reported as deferred revenue liability.

 

We record freight income as a component of net sales and record freight costs as a component of cost of goods sold. Total sales do not include sales tax as we consider ourselves a pass-through conduit for collecting and remitting applicable sales taxes.

 

Other revenue is defined in Note 7 - Leases.

 

Actual and estimated sales returns are classified as a reduction of net sales. We estimate and accrue a reserve for product returns based on our return policy and historical experience. Our product returns policy allows for distributors to return product only upon termination of his or her distributorship. Allowable returns are limited to saleable product which was purchased within twelve months of the termination for a refund of 100% of the original purchase price less any distributor royalties and commissions received relating to the original purchase of the returned products. For the year to date periods ending June 30, 2019 and 2018, total returns as a percent of net sales were approximately 0.07% and 0.26%, respectively.

 

We classify our net sales into two categories of sales products, plus freight income, and other revenue:

 

   

Three months ended June 30

   

Six months ended June 30

 
   

2019

   

2018

   

2019

   

2018

 

Net sales by product category

                               

Nutritional and dietary supplements

  $ 7,284,897     $ 7,606,674     $ 15,782,247     $ 16,676,031  

Sales aids, membership fees, and other

    318,144       313,922       631,791       635,946  

Freight income

    479,881       539,145       999,822       1,151,003  

Other revenue

    174,091       -       332,657       -  

Total net sales

  $ 8,257,013     $ 8,459,741     $ 17,746,517     $ 18,462,980  

 

We operate in one reportable segment, a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. These operating units are based on geographic regions, as follows:

 

   

Three months ended June 30

   

Six months ended June 30

 
   

2019

   

2018

   

2019

   

2018

 

Net sales by geographic region

                               

United States

  $ 5,904,605     $ 6,336,387     $ 13,016,378     $ 14,006,448  

Australia/New Zealand

    132,330       177,536       309,377       409,464  

Canada

    140,029       161,557       339,428       403,677  

Mexico

    152,569       112,411       288,595       219,782  

Europe (1)

    756,264       1,030,546       1,694,933       2,195,430  

Asia (2)

    1,171,216       641,304       2,097,806       1,228,179  

Total net sales

  $ 8,257,013     $ 8,459,741     $ 17,746,517     $ 18,462,980  

 

(1)  

Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.

(2)   

Asia consists of Philippines, Malaysia, and Singapore.

 

17

 
 

 

FORWARD-LOOKING STATEMENTS

 

This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this annual report to conform such statements to actual results or to changes in our opinions or expectations.

 

Item No. 2 - Management s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this Quarterly Report on Form 10- Q . The following discussion and analysis discusses the financial condition and results of our operations on a consolidated basis, unless otherwise indicated.

 

Overview

 

We are a developer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. We sell our products through an international network marketing system utilizing independent distributors. Sales in the United States represented approximately 73.4% of worldwide net sales for the six months ended June 30, 2019 and 75.9% of worldwide net sales for the six months ended June 30, 2018. Our international operations currently generate sales through distributor networks with facilities in Australia, Canada, Malaysia, Mexico, the Philippines, and the United Kingdom. We also operate in Ireland, France, Germany, Austria and the Netherlands from our United Kingdom distribution center, and in New Zealand from our Australia office.

 

We derive our revenues principally through product sales made by our global independent distributor base, which, as of June 30, 2019, consisted of approximately 32,870 distributors and preferred customers. Our sales can be affected by several factors, including our ability to attract new distributors and retain our existing distributor base, our ability to properly train and motivate our distributor base and our ability to develop new products and successfully maintain our current product line.

 

All of our sales to distributors outside the United States are made in the respective local currency; therefore, our earnings and cash flows are subject to fluctuations due to changes in foreign currency rates as compared to the U.S. dollar. As a result, exchange rate fluctuations may have an effect on sales and gross margins. U.S. generally accepted accounting practices require that our results from operations be converted to U.S. dollars for reporting purposes. Consequently, our reported earnings may be significantly affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. Products purchased by our foreign subsidiaries are acquired in U.S. dollars and sold in local country currency. From time to time, we enter into foreign exchange forward contracts to mitigate our foreign currency exchange risk.

 

Components of Net Sales and Expense

 

Product sales represent the actual product purchase price typically paid by our distributors, after giving effect to distributor allowances, which can range from 20% to 40% of suggested retail price, depending on the rank of a particular distributor. Freight income represents the amounts billed to distributors for shipping costs. We record net sales and the related commission expense when the merchandise is shipped. Other revenue included in net sales now includes the leasing revenue, plus common area expense billings, on the lease of the manufacturing portion of our building to Nutracom, LLC (“Nutracom”) as of January 1, 2019 after the adoption of ASU 2016-02.

 

Our primary expenses include cost of products sold, distributor royalties and commissions and selling, general and administrative expenses.

 

In 2018, our cost of goods sold primarily consists of expenses related to raw materials, labor, quality control and overhead directly associated with production of our products and sales materials, as well as shipping costs relating to the shipment of products to distributors, and duties and taxes associated with product exports. Cost of goods sold is impacted by the cost of the ingredients used in our products, the cost of shipping distributors’ orders, along with our efficiency in managing the production of our products. For 2019, we no longer manufacture our products; therefore, the costs consist of the purchase price of the products, along with shipping costs, and duties and taxes where applicable. Cost of goods sold also include the costs related to leasing income now included in net sales after the adoption of ASU 2016-02.

 

Distributor royalties and commissions are monthly payments made to distributors based on products sold in their downline organization. Based on our distributor agreements, these expenses have typically approximated 23% of sales at suggested retail. Wholesale pricing discounts on distributor orders are based on the retail value of the product. Distributor royalties and commissions are paid on an amount referred to as the business value (“BV”), which typically ranges between 80% and 90% of the retail price of each product. Also, we include other sales leadership bonuses, such as Ambassador bonuses, within this caption. Overall, distributor royalties and commissions remain directly related to the level of our sales and should continue at comparable levels as a percentage of net sales going forward.

 

Selling, general and administrative expenses include the compensation and benefits paid to our employees, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses. These other corporate administrative expenses include professional fees, depreciation and amortization, occupancy costs, communication costs and other similar operating expenses. Selling, general and administrative expenses can be affected by a number of factors, including staffing levels and the cost of providing competitive salaries and benefits; the amount we decide to invest in distributor training and motivational initiatives; and the cost of regulatory compliance.

 

18

 

 

Results of Operations

  

Net Sales. Overall net sales decreased by 2.4% in the three months ended June 30, 2019 compared to the same period in 2018. During the second quarter of 2019 (“Q2 2019”), sales in the United States decreased by 6.8%, and international sales increased by 10.8% over the prior-year period. International sales, when reported in U.S. dollars, were negatively impacted by a stronger U.S. dollar versus most of the currencies of the markets where we do business. Excluding the impact of currency exchange fluctuation, international sales increased by 13.2%.

 

The following table summarizes net sales by geographic market for the three months ended June 30, 2019 and 2018.

 

   

Three months ended June 3 0 ,

               
   

20 1 9

 

20 1 8

 

Change from prior year

   

Amount

 

% of Net

Sales

 

Amount

 

% of Net

Sales

 

Amount

 

%

   

(dollars in thousands)

                 

United States

  $ 5,905       71.5

%

  $ 6,336       74.9

%

  $ (431

)

    (6.8

)%

Australia/New Zealand

    132       1.6       178       2.1       (46

)

    (25.8

)

Canada

    140       1.7       162       1.9       (22

)

    (13.6

)

Mexico

    153       1.8       112       1.3       41       36.6  

Europe

    756       9.2       1,031       12.2       (275

)

    (26.7

)

Asia

    1,171       14.2       641       7.6       530       82.7  

Consolidated total

  $ 8,257       100.0

%

  $ 8,460       100.0

%

  $ (203

)

    (2.4

)%

 

The following table summarizes net sales by geographic market for the six months ended June 30, 2019 and 2018.

 

   

Six months ended June 30,

               
   

201 9

 

201 8

 

Change from prior year

   

Amount

 

% of Net

Sales

 

Amount

 

% of Net

Sales

 

Amount

 

%

   

(dollars in thousands)

                 

United States

  $ 13,016       73.4

%

  $ 14,006       75.9

%

  $ (990

)

    (7.1

)%

Australia/New Zealand

    309       1.7       410       2.2       (101

)

    (24.6

)

Canada

    340       1.9       404       2.2       (64

)

    (15.8

)

Mexico

    289       1.6       220       1.2       69       31.4  

Europe

    1,695       9.6       2,195       11.9       (500

)

    (22.8

)

Asia

    2,098       11.8       1,228       6.6       870       70.8  

Consolidated total

  $ 17,747       100.0

%

  $ 18,463       100.0

%

  $ (716

)

    (3.9

)%

 

The following table sets forth, as of June 30, 2019 and 2018, the number of our active distributors and Master Affiliates and above. The total number of active distributors includes Master Affiliates and above. We define an active distributor as one that enrolls as a distributor or renews his or her distributorship during the prior twelve months. Master Affiliates and above are distributors that have attained the highest level of discount and are eligible for royalties generated by Master Affiliate groups in their downline organization. We include Preferred Customers as part of our Active Distributor count, and Preferred Customers represent approximately 7,520 and 4,760 of the Active Distributor count as of June 30, 2019 and 2018, respectively.

 

   

June 30, 201 9

 

June 30, 201 8

 

% Change

   

Active

Distributors

and Preferred Customers

 

Master

Affiliates and

Above

 

Active

Distributors

and Preferred Customers

 

Master

Affiliates and

Above

 

Active

Distributors

and Preferred Customers

 

Master

Affiliates and

Above

United States

    19,290       1,980       21,060       2,270       (8.4

)%

    (12.8

)%

Australia/New Zealand

    910       70       1,030       80       (11.7

)

    (12.5

)

Canada

    530       60       580       80       (8.6

)

    (25.0

)

Mexico

    1,190       100       780       70       52.6       42.9  

Europe

    2,530       300       3,290       380       (23.1

)

    (21.1

)

Asia

    8,420       470       4,400       320       91.4       46.9  

Consolidated total

    32,870       2,980       31,140       3,200       5.6

%

    (6.9

)%

 

19

 


Use of Non-GAAP Financial Information

 

Net sales expressed in local currency or net sales adjusted for the impact of foreign currency fluctuation are non-GAAP financial measures. We use these measurements to assess the level of business activity in a foreign market, absent the impact of foreign currency fluctuation relative to the United States dollar, which our local management has no ability to influence. This is a meaningful measurement to management, and we believe this is a useful measurement to provide to shareholders.

 

The following table provides key statistics related to distributor activity by market and should be read in conjunction with the following discussion. Adjusted results should be considered only in conjunction with results reported according to accounting principles generally accepted in the United States.

 

Distributor Activity by Market

                                                 

International

   

United States

 

AUS/NZ

 

Canada

 

Mexico

 

Europe

 

Asia

 

-- Total

Sales in USD (in 000's):

                                                       

Quarter ended 6/30/2019

  $ 5,905     $ 132     $ 140     $ 153     $ 756     $ 1,171     $ 2,352  

Quarter ended 6/30/2018

  $ 6,336     $ 178     $ 162     $ 112     $ 1,031     $ 641     $ 2,124  
                                                         

% change in sales-Q2 2019 vs. Q2 2018:

                                                       

in USD

    (6.8 )%     (25.8 )%     (13.6 )%     36.6 %     (26.7 )%     82.7 %     10.8 %

due to currency fluctuation

    -       (5.8 )%     (3.2 )%     2.1 %     (4.3 )%     0.9 %     (2.4 )%

Sales in local currency (non-GAAP)

    (6.8 )%     (20.0 )%     (10.4 )%     34.5 %     (22.4 )%     81.8 %     13.2 %
                                                         

# of new distributors-Q2 2019 (1)

    1,061       35       22       193       262       1,719       2,231  

# of new distributors-Q2 2018 (1)

    979       37       20       140       373       664       1,234  

% change

    8.4 %     (5.4 )%     10.0 %     37.9 %     (29.8 )%     158.9 %     80.8 %
                                                         

# of new Master Affiliates-Q2 2019

    124       2       2       14       14       118       150  

# of new Master Affiliates-Q2 2018

    84       0       3       15       31       27       76  

% change

    47.6 %     N/A       (33.3 )%     (6.7 )%     (54.8 )%     337.0 %     97.4 %
                                                         

# of Product orders-Q2 2019

    24,900       916       558       1,100       2,715       10,512       15,801  

# of Product orders-Q2 2018

    26,092       1,093       604       887       3,347       7,113       13,044  

% change

    (4.6 )%     (16.2 )%     (7.6 )%     24.0 %     (18.9 )%     47.8 %     21.1 %

 

                                                   

International

   

United States

 

AUS/NZ

 

Canada

 

Mexico

 

Europe

 

Asia

 

-- Total

Sales in USD (in 000's):

                                                       

YTD ended 6/30/2019

  $ 13,016     $ 309     $ 340     $ 289     $ 1,695     $ 2,098     $ 4,731  

YTD ended 6/30/2018

  $ 14,006     $ 410     $ 404     $ 220     $ 2,195     $ 1,228     $ 4,457  
                                                         

% change in sales-YTD 2019 vs. YTD 2018:

                                                       

in USD

    (7.1 )%     (24.6 )%     (15.8 )%     31.4 %     (22.8 )%     70.8 %     6.1 %

due to currency fluctuation

    -       (6.7 )%     (3.6 )%     (0.8 )%     (4.9 )%     (1.0 )%     (3.7 )%

Sales in local currency (non-GAAP)

    (7.1 )%     (17.9 )%     (12.2 )%     32.2 %     (17.9 )%     71.8 %     9.8 %
                                                         

# of new distributors-YTD 2019 (2)

    1,963       63       34       444       523       4,214       5,278  

# of new distributors-YTD 2018 (2)

    1,957       78       58       223       715       1,203       2,277  

% change

    0.3 %     (19.2 )%     (41.4 )%     99.1 %     (26.9 )%     250.3 %     131.8 %
                                                         

# of new Master Affiliates-YTD 2019

    264       3       2       22       33       217       277  

# of new Master Affiliates-YTD 2018

    184       6       10       25       61       81       183  

% change

    43.5 %     (50.0 )%     (80.0 )%     (12.0 )%     (45.9 )%     167.9 %     51.4 %
                                                         

# of Product orders-YTD 2019

    50,658       1,891       1,116       2,075       5,746       21,175       32,003  

# of Product orders-YTD 2018

    52,729       2,297       1,235       1,638       6,954       13,666       25,790  

% change

    (3.9 )%     (17.7 )%     (9.6 )%     26.7 %     (17.4 )%     54.9 %     24.1 %

 


(1)  

The new distributor totals for Q2 2019 and Q2 2018 include 1,569 and 943, respectively, of new worldwide preferred customers.

(2)  

The new distributor totals for YTD 2019 and YTD 2018 include 4,064 and 1,725, respectively, of new worldwide preferred customers.

 

20

 

 

United States

 

 

Net sales in the United States declined by 6.8% in Q2 2019 compared to the prior-year quarter; however, new distributor and preferred customer enrollments increased by 8.4% in Q2 2019 compared to the prior-year quarter. New distributor enrollments have been improving since we reduced the enrollment fee for distributors from $40 to $20 in the United States in May 2019.

 

Products in the LunaRich line, including Reliv Now® and LunaRich X™, continued to perform well, constituting 14.9% and 11.9% of net sales in the United States, respectively, in Q2 2019. Reliv NOW and LunaRich X represented 16.0% and 12.3%, respectively, of net sales in the United States in the prior-year quarter.

 

New Master Affiliate qualifications increased by 47.6% and 43.5% in Q2 2019 and YTD 2019, respectively, in response to a cash bonus incentive in place beginning in Q1 2019.

 

Distributor retention was 77.8% for the twelve month period ended June 30, 2019 compared to 73.5% for all of 2018. Distributor retention is determined by the percentage of active distributors from 2018 that renewed their distributorships in 2019.

 

Our average order size in Q2 2019 increased by 1.0% to $318 at suggested retail value compared to the prior-year quarter. However, the number of product orders decreased by 4.6% in Q2 2019 compared to the prior year quarter.

 

In March 2019, we introduced a feature in our compensation plan in the United States to pay the wholesale profit earned by distributors on a weekly basis. This does not alter the timing of the expense recognition of the commission earnings, but does speed up the timing of the payment.

 

In January 2019, we sold substantially all of the machinery, equipment, inventory, tools and other assets and materials used in our manufacturing operations to Nutracom. Nutracom is substantially owned and is controlled by former officers/employees. Nutracom is leasing the manufacturing space in our facility for a period of seven years, with an option to renew for a five-year term. We also entered into agreements whereby Nutracom will continue to manufacture our core products on our premises for a period of seven years.

 

In late June 2019, we introduced our RLV line of hemp-extract products. Initially, the RLV line includes three liquid tinctures and one balm. All of the RLV products are derived from organically-grown, non-GMO hemp.

 

International Operations

 

 

The average foreign exchange rate for the U.S. dollar for YTD 2019 was stronger against all of the currencies in which we conduct business.

 

Australia/New Zealand and Canadian net sales in Q2 2019 decreased by 20.0% and 10.4%, respectively, in local currency compared to the prior-year quarter as the result of decreased distributor activity in the market.

 

Net sales in Mexico increased by 34.5% in local currency in Q2 2019 compared to the prior-year quarter. Distributor activity has increased in recent quarters subsequent to retaining a sales consultant with prior experience in network marketing sales in Mexico. New distributor enrollments increased by 37.9% in Q2 2019 compared to the prior-year quarter. Product order count increased by 24.0% in Q2 2019 as well.

 

Net sales in Europe decreased by 22.4% in local currency in Q2 2019 compared to the prior-year quarter. Distributor activity continues to decline both in the form of new distributor and preferred customer enrollments and number of product orders placed in the region.

 

Sales in Asia increased by 81.8% in local currency in Q2 2019 compared to the prior-year quarter, driven primarily by sales growth in the Philippines, our largest market in the region. All measures of distributor and preferred customer activity have grown rapidly. New distributor and preferred customer enrollments grew to 1,719 in Q2 2019 compared to 664 in the prior-year quarter. The number of new Master Affiliate qualifications grew to 118 in Q2 2019 compared to 27 in the prior year quarter and the product order count grew by 47.8% in Q2 2019.

 

21

 

 

Costs and Expenses

 

The following table sets forth selected results of our operations expressed as a percentage of net sales for the three- and six-month periods ended June 30, 2019 and 2018. Our results of operations for the periods described below are not necessarily indicative of results of operations for future periods.

 

Income statement data

                               

(amounts in thousands)

 

Three months ended

   

June 30, 2019

 

June 30, 2018

   

Amount

 

% of net sales

 

Amount

 

% of net sales

                                 

Net sales

  $ 8,257       100.0

%

  $ 8,460       100.0

%

Costs and expenses:

                               

Cost of goods sold

    2,269       27.5       2,356       27.9  

Distributor royalties and commissions

    2,665       32.3       2,827       33.4  

Selling, general and administrative

    3,689       44.6       4,216       49.8  
                                 

Loss from operations

    (366 )     (4.4 )     (939 )     (11.1 )

Interest income

    46       0.5       23       0.3  

Interest expense

    (10 )     (0.1 )     (45 )     (0.6 )

Other income

    5       0.1       7       0.1  

Gain (loss) on sale of fixed assets

    -       -       (1 )     -  
                                 

Loss before income taxes

    (325 )     (3.9 )     (955 )     (11.3 )

Provision for income taxes

    63       0.8       23       0.3  
                                 

Net loss

  $ (388 )     (4.7

)%

  $ (978 )     (11.6

)%

                                 

Loss per common share-Basic and Diluted

  $ (0.22 )           $ (0.53 )        

 

   

Six months ended

   

June 30, 2019

 

June 30, 2018

   

Amount

 

% of net sales

 

Amount

 

% of net sales

                                 

Net sales

  $ 17,747       100.0

%

  $ 18,463       100.0

%

Costs and expenses:

                               

Cost of goods sold

    4,703       26.5       4,706       25.5  

Distributor royalties and commissions

    5,783       32.6       6,219       33.7  

Selling, general and administrative

    7,428       41.8       8,702       47.1  
                                 

Loss from operations

    (167 )     (0.9 )     (1,164 )     (6.3 )

Interest income

    95       0.5       48       0.3  

Interest expense

    (15 )     (0.1 )     (77 )     (0.5 )

Other income (loss)

    (1 )     -       17       0.1  

Gain (loss) on sale of fixed assets

    435       2.4       -       -  
                                 

Income (loss) before income taxes

    347       1.9       (1,176 )     (6.4 )

Provision for income taxes

    111       0.6       40       0.2  
                                 

Net income (loss)

  $ 236       1.3

%

  $ (1,216 )     (6.6

)%

                                 

Earnings (loss) per common share- Basic and Diluted

  $ 0.13             $ (0.66 )        

 

22

 

 

Cost of Goods Sold:

 

The cost of goods sold as a percentage of net sales in Q2 2019 decreased by 0.4% compared to the prior-year period and increased by 1.0% in YTD 2019 versus the prior-year YTD basis. The cost of goods sold as a percentage of net sales in Q2 2018 was negatively impacted by manufacturing expenses and plant utilization issues that no longer exist subsequent to our transaction with Nutracom. However, for YTD 2019 the cost of goods as a percentage continues to be negatively impacted by several factors, including promotions in the United States that reduced our freight income and the cost of sales associated with the leasing income now included in net sales subsequent to the adoption of ASU 2016-02.

 

Distributor Royalties and Commissions:

 

Distributor royalties and commissions as a percentage of net sales for Q2 2019 and YTD 2019 decreased by 1.1% of net sales when compared to the prior-year period. This decrease is due to the inclusion of leasing revenue in current year net sales on which distributor commissions are not paid.

 

Selling, General and Administrative Expenses:

 

Selling, general and administrative (“SGA”) expenses declined by $527,000 and by $1.3 million in Q2 2019 and YTD 2019, respectively, compared to the prior-year periods.

 

SGA expenses, including salaries and other staffing expenses, related to the manufacturing/Nutracom operations represent a net decrease of $624,000 of the SGA decrease in YTD 2019, compared to the prior-year period.

 

Other SGA salaries, other staffing expenses, benefits, and incentive compensation decreased in the aggregate by $276,000 in YTD 2019, compared to the prior-year period.

 

Sales and marketing expenses decreased by $266,000 in YTD 2019 compared to the prior-year period. Components of the decrease include:

 

$164,000 decrease in promotions expense, as we did not sponsor an incentive trip in the United States in YTD 2019 in contrast to the prior-year period.

 

$22,000 decrease in distributor conferences and meeting expenses.

 

$80,000 decrease in development and other sales expenses.

 

Other general and administrative expenses decreased by $73,000 in YTD 2019 versus the prior-year period.

 

Other Income/Expense:

 

The other income/expense in YTD 2019 and 2018 is primarily the result of foreign currency exchange gains (losses) on intercompany debt denominated in U.S. dollars in certain of our subsidiaries.

 

YTD 2019 includes $435,000 in income from the sale of our manufacturing equipment as part of the asset sale with Nutracom during Q1.

 

Income Taxes :

 

We reported an income tax expense of $111,000 for YTD 2019 related to income taxes on our earnings in our Philippine entity and minimum U.S. state income tax expense.

 

See Note 8 of the Condensed Consolidated Financial Statements for additional detail regarding income taxes.

 

Net Income :

 

We reported a net loss of $388,000 in Q2 2019 compared to a net loss of $978,000 in the prior-year quarter and net income of $236,000 in YTD 2019 compared to a net loss of $1.2 million in YTD 2018. On a YTD basis, the improvement in 2019 is primarily the result of the decrease in SGA expenses, coupled with the gain on the sale of fixed assets as part of the asset sale with Nutracom.

 

23

 

 

Liquidity and Capital Resources

 

During the first six months of 2019, we used $644,000 of net cash in operating activities, $60,000 was provided by investing activities, and $500,000 was provided by financing activities. This compares to $256,000 of net cash used in operating activities, $4,000 provided by investing activities, and $190,000 used in financing activities in the same period of 2018. Cash and cash equivalents decreased by $71,000 to $1.92 million as of June 30, 2019 compared to December 31, 2018.

 

Significant changes in working capital items consisted of an increase of $715,000 in accounts/notes receivable and deposits, a decrease in inventory of $759,000, an increase in prepaid expenses/other current assets of $296,000, and a decrease of $293,000 in accounts payable and other accrued expenses in the first six months of 2019. The increase in accounts/notes receivable and deposits is primarily the result of deposits required on production purchase orders to Nutracom, in accordance with the supply agreement executed as of January 1, 2019. The decrease in inventory is the result of the timing of the transfer of finished goods from Nutracom to us under the terms of the supply agreement, partially offset by cash payments for finished goods. The increase in prepaid expenses/other current assets primarily represents the annual premium payments made in the first quarter of 2019 on most of the corporate business insurance policies, and the decrease in accounts payable and other accrued expenses is primarily the result of a reduction in payables related to production in light of the supply agreement with Nutracom.

 

Investing activities during the first six months of 2019 consisted of a net investment of $50,000 for capital expenditures, offset by payments received on notes receivable with related parties of $110,000. Financing activities during the first six months of 2019 consisted of $500,000 in proceeds from line of credit borrowings.

 

Stockholders’ equity decreased to $11.74 million at June 30, 2019 compared to $11.99 million at December 31, 2018. The decrease is primarily due to the treasury stock of $540,000 acquired under the purchase agreement with Nutracom; offset by our net income during the first six months of 2019 of $236,000. Our working capital balance was $2.22 million at June 30, 2019 compared to $4.17 million at December 31, 2018. The current ratio at June 30, 2019 was 1.50 compared to 2.07 at December 31, 2018.

 

In September 2018, the maximum borrowing amount on our revolving line of credit was reduced from $2.0 million to $750,000. As amended, the revolver’s maturity date remained April 29, 2019 and the revolver’s interest rate continued to be based on the 30-day LIBOR plus 2.25%. As of June 30, 2019, we have borrowed $500,000 under our revolving line of credit. In March 2019, the revolving line of credit’s maturity date was extended to April 28, 2020, and the interest rate was revised to the 30-day LIBOR plus 3.00%. As amended, the revolver’s maximum borrowing amount remains $750,000. Borrowings under the lending agreement continue to be secured by all our tangible and intangible assets and by a mortgage on the real estate of our corporate headquarters.

 

We have experienced significant losses over the last several years and may experience a loss in 2019. Our existing cash, cash equivalents, operating revenue and borrowing facilities may not be sufficient to fund our operating expenses through the next 12 months which would require us to obtain additional financing before that time. We have taken several steps which management believes will result in an improved financial position, operating results, and cash flows. Over the last several years, we have also taken other cost cutting measures including reductions in staff, freezing or lowering salaries, limiting promotional events all in an effort to reduce operating expenses.

 

As detailed in Note 2 of the accompanying consolidated financial statements, in January 2019, we entered into a Purchase Agreement with Nutracom, LLC (Nutracom) pursuant to which Nutracom purchased the assets used by us in our manufacturing operations. Assets purchased by Nutracom from us were financed by us under payment terms scheduled to provide incoming funds to us of $100,000 or more per year. We have also entered into an agreement for Nutracom to lease a significant portion of our headquarters building. Management believes that these transactions with Nutracom will be favorable to our financial position, operating results, and cash flows; however, there are risks and uncertainties which arise with these Nutracom transactions and their impact to our operations.

 

Should the aforementioned changes to the company’s operations not provide sufficient cash flow improvement or should we be unable to obtain sufficient additional capital or borrowings, we may have to engage in any or all of the following activities: (i) monetize our headquarters building via traditional bank lending or a sale and leaseback-type transaction; (ii) monetize a note receivable from a distributor; (iii) modify our distributor promotions, incentives, and other activities; (iv) cease operations in certain geographic regions, and (v) reduce employee compensation and benefits.

 

We may not be able to obtain sufficient additional funding through monetizing certain of our existing assets, sourcing additional borrowings, and issuing additional equity, or any other means, and if we are able to do so, these available sources of funds may not be on satisfactory terms. Our ability to raise additional capital in the equity markets, should we choose to do so, is dependent on a number of factors, including, but not limited to, the market demand for our common stock, which itself is subject to a number of business risks and uncertainties, as well as the uncertainty that we would be able to raise such additional capital at a price or on terms that are favorable to us.

 

These actions may have a material adverse impact on our ability to achieve certain of our planned objectives. Even if we are able to source additional funding, we may be forced to significantly reduce our operations if our operating performance does not improve. If we are unable to source additional funding, we may be forced to significantly reduce or shut down our operations. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effect on our assets or liabilities should we not be able to continue as a going concern.

 

24

 

 

Critical Accounting Policies

 

A summary of our critical accounting policies and estimates is presented in our 2018 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2019. Except for the required adoption of ASU No. 2016-02, our critical accounting policies remain unchanged as of June 30, 2019.

 

 

Item No. 4 - Controls and Procedures

 

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2019. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of June 30, 2019, to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the second quarter of 2019 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

25

 

 

PART II – OTHER INFORMATION

  

Item No. 6 Exhibits

 

Exhibit

Number

Document

 

10.1

Agreement dated June 1, 2019 with Nutracom, LLC to modify Purchase Agreement and Secured Promissory Note dated January 1, 2019 (filed herewith).

 

31.1

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).

 

31.2

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).

 

32

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).

 

101

Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss), (iii) the Condensed Consolidated Statements of Cash Flows, (iv) Condensed Consolidated Statements of Stockholders’ Equity, and (v) the Notes to Condensed Consolidated Financial Statements.

 

26

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

RELIV INTERNATIONAL, INC.

 

 

 

 

By:

/s/  Ryan A. Montgomery

 

 

Ryan A. Montgomery, Chief Executive Officer

 

 

 

 

Date: August 14, 2019

 

 

 

 

By:

/s/  Steven D. Albright

 

 

Steven D. Albright, Chief Financial Officer (and accounting officer)

 

 

Date: August 14, 2019

 

27

Reliv (NASDAQ:RELV)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Reliv Charts.
Reliv (NASDAQ:RELV)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Reliv Charts.